top of page
  • Writer's pictureKiran Dhillon

HER2 ICD DNA vaccine study featured on Good Morning America & ABC News

We're excited to see the findings from our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD DNA vaccine in patients with advanced stage HER2+ breast cancer is being shared out through various media outlets. Check out the videos of the coverage by Good Morning America and ABC News.

ABC News:


Post: Blog2_Post
bottom of page